Insider Trading Alert - LYB, PMC And TILE Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Yesterday, June 3, 2015, 102 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $0.88 to $2,000,000.00.

Highlighted Stocks Traded by Insiders:

LyondellBasell Industries (LYB) - FREE Research Report

Kaplan Jeffrey A, who is EVP & Chief Legal Officer at LyondellBasell Industries, sold 5,000 shares at $102.51 on June 3, 2015. Following this transaction, the EVP & Chief Legal Officer owned 7,705 shares meaning that the stake was reduced by 39.35% with the 5,000-share transaction.

The shares most recently traded at $100.05, down $2.46, or 2.46% since the insider transaction. Historical insider transactions for LyondellBasell Industries go as follows:

  • 4-Week # shares bought: 17
  • 4-Week # shares sold: 76,070
  • 12-Week # shares bought: 17
  • 12-Week # shares sold: 110,452
  • 24-Week # shares bought: 17
  • 24-Week # shares sold: 110,833

The average volume for LyondellBasell Industries has been 3.6 million shares per day over the past 30 days. LyondellBasell Industries has a market cap of $48.4 billion and is part of the basic materials sector and chemicals industry. Shares are up 29.46% year-to-date as of the close of trading on Wednesday.

LyondellBasell Industries N.V. operates as a manufacturer of chemicals and polymers, refiner of crude oil, producer of gasoline blending components, and developer and licensor of technologies for production of polymers. The stock currently has a dividend yield of 3.05%. The company has a P/E ratio of 11.8. Currently, there are 7 analysts who rate LyondellBasell Industries a buy, no analysts rate it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on LYB - FREE

TheStreet Quant Ratings rates LyondellBasell Industries as a buy. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, increase in net income, notable return on equity, attractive valuation levels and good cash flow from operations. We feel its strengths outweigh the fact that the company shows low profit margins. Get the full LyondellBasell Industries Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Pharmerica (PMC) - FREE Research Report

Lindemoen Mark, who is SVP Sales and Client Services at Pharmerica, sold 4,500 shares at $33.27 on June 3, 2015. Following this transaction, the SVP Sales and Client Services owned 25,357 shares meaning that the stake was reduced by 15.07% with the 4,500-share transaction.

The shares most recently traded at $32.14, down $1.13, or 3.51% since the insider transaction. Historical insider transactions for Pharmerica go as follows:

  • 4-Week # shares sold: 16,180
  • 12-Week # shares sold: 27,019
  • 24-Week # shares sold: 38,293

The average volume for Pharmerica has been 321,600 shares per day over the past 30 days. Pharmerica has a market cap of $1.0 billion and is part of the services sector and retail industry. Shares are up 57.41% year-to-date as of the close of trading on Wednesday.

PharMerica Corporation operates as an institutional pharmacy services company in the United States. The company offers services to healthcare facilities; pharmacy management services to hospitals; specialty infusion services to patients outside hospitals; and oncology pharmacy services. The company has a P/E ratio of 89.0. Currently, there are 4 analysts who rate Pharmerica a buy, 1 analyst rates it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on PMC - FREE

TheStreet Quant Ratings rates Pharmerica as a buy. The company's strengths can be seen in multiple areas, such as its increase in net income, revenue growth, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations and solid stock price performance. We feel its strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Pharmerica Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Interface (TILE) - FREE Research Report

Wells John R, who is Sr. Vice President at Interface, sold 4,444 shares at $21.73 on June 3, 2015. Following this transaction, the Sr. Vice President owned 204,209 shares meaning that the stake was reduced by 2.13% with the 4,444-share transaction.

The shares most recently traded at $22.05, up $0.32, or 1.44% since the insider transaction. Historical insider transactions for Interface go as follows:

  • 4-Week # shares bought: 18,000
  • 4-Week # shares sold: 5,000
  • 12-Week # shares bought: 18,000
  • 12-Week # shares sold: 52,513
  • 24-Week # shares bought: 18,000
  • 24-Week # shares sold: 132,163

The average volume for Interface has been 494,900 shares per day over the past 30 days. Interface has a market cap of $1.4 billion and is part of the industrial goods sector and industrial industry. Shares are up 34.24% year-to-date as of the close of trading on Wednesday.

Interface, Inc. designs, produces, and sells modular carpet products primarily in the Americas, Europe, and the Asia-Pacific. The stock currently has a dividend yield of 0.74%. The company has a P/E ratio of 43.5. Currently, there are 5 analysts who rate Interface a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on TILE - FREE

TheStreet Quant Ratings rates Interface as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, expanding profit margins, good cash flow from operations and increase in net income. We feel its strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Interface Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

More from Markets

Ackman Investment Buoys Lowe's; DraftKings Responds to FanDuel Merger -- ICYMI

Ackman Investment Buoys Lowe's; DraftKings Responds to FanDuel Merger -- ICYMI

Replay: Jim Cramer on the Markets, Tiffany, Micron Technology and Union Pacific

Replay: Jim Cramer on the Markets, Tiffany, Micron Technology and Union Pacific

Carnival CEO Arnold Donald: China Will Become the Largest Cruise Market

Carnival CEO Arnold Donald: China Will Become the Largest Cruise Market

Red Robin Slumps After Earnings Miss

Red Robin Slumps After Earnings Miss

Owner of Moviepass Sees Stock Plummet

Owner of Moviepass Sees Stock Plummet